18.12
-0.73
(-3.87%)
At close: January 10 at 4:00:00 PM EST
18.54
+0.42
+(2.32%)
After hours: January 10 at 7:59:45 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 12 | 15 | 15 |
| Avg. Estimate | 0.44 | 0.42 | 1.85 | 1.99 |
| Low Estimate | 0.41 | 0.38 | 1.82 | 1.67 |
| High Estimate | 0.51 | 0.5 | 1.93 | 2.43 |
| Year Ago EPS | 0.44 | 0.42 | 1.83 | 1.85 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 9 | 15 | 15 |
| Avg. Estimate | 921.04M | 912.88M | 3.81B | 3.76B |
| Low Estimate | 907M | 880M | 3.79B | 3.66B |
| High Estimate | 932.3M | 932M | 3.85B | 3.96B |
| Year Ago Sales | 1.01B | 953M | 3.96B | 3.81B |
| Sales Growth (year/est) | -8.99% | -4.21% | -3.86% | -1.45% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.44 | 0.42 | 0.49 | 0.48 |
| EPS Actual | 0.44 | 0.42 | 0.49 | 0.5 |
| Difference | 0 | 0 | -0 | 0.02 |
| Surprise % | 1.12% | 0.01% | -0.99% | 5.07% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.44 | 0.42 | 1.84 | 1.93 |
| 7 Days Ago | 0.44 | 0.42 | 1.85 | 1.99 |
| 30 Days Ago | 0.44 | 0.43 | 1.85 | 1.99 |
| 60 Days Ago | 0.44 | 0.45 | 1.85 | 2.01 |
| 90 Days Ago | 0.6 | 0.51 | 1.98 | 2.3 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 12 | 1 | 13 | 1 |
| Down Last 30 Days | 12 | 2 | 13 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| XRAY | -1.00% | 0.65% | 0.85% | 7.87% |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
| Downgrade | Evercore ISI Group: Outperform to In-Line | 1/7/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 12/17/2024 |
| Initiated | Mizuho: Neutral | 12/4/2024 |
| Maintains | UBS: Buy to Buy | 12/3/2024 |
| Maintains | Barrington Research: Outperform to Outperform | 11/8/2024 |
| Maintains | Baird: Neutral to Neutral | 11/8/2024 |
Related Tickers
NVST Envista Holdings Corporation
18.58
-3.08%
TFX Teleflex Incorporated
174.61
-1.88%
BAX Baxter International Inc.
29.42
-0.57%
COO The Cooper Companies, Inc.
90.31
-1.71%
HOLX Hologic, Inc.
71.70
-1.43%
MMSI Merit Medical Systems, Inc.
96.16
-2.02%
BDX Becton, Dickinson and Company
233.67
-0.32%
ALGN Align Technology, Inc.
212.12
-1.51%
STAA STAAR Surgical Company
23.00
-0.52%
RMD ResMed Inc.
233.82
-1.00%